Blue-Zone Technologies is a Toronto-based clean‑tech pharmaceutical company that sustainably captures and recovers waste anesthetic gases and converts them into branded generic inhalation anesthetics. Founded in 1999 by Dusanka Filipovic and led by CEO Kipton Lade, the company runs a fully operational, GMP‑compliant, Health Canada‑licensed Drug Establishment Facility for anesthetic recovery, raw material and final product production. Blue-Zone collects unused anesthetics that would normally be vented into the environment and processes the collected material into its pure form, providing a sustainable and cost‑efficient source of inhalation anesthetic drugs. The company raised $8m in institutional financing in a round led by the Canadian venture capital arm of Crédit Mutuel Equity and Round Pound Ventures, LLC. Blue-Zone intends to use the proceeds to expand operations and broaden its business reach.

Total raised

$8M

Funding rounds

1

Latest round

Equity

Latest activity

Oct 2022